The COVID-19 cases are increasing day by day all around the world. There are around 13.1 million cases and around 5,270,696 are active cases. There are countries with the worst conditions. And some also control the spread of corona. At such times all we can do is stay safe unless they come up with a vaccine. Russia corona vaccine is the first-ever vaccine clearing clinical trial safely. The vaccine is in development by Sechenov University.
The first clinical trial on the volunteers at Sechenov First Moscow State Medical University was completed successfully on 12th July 2020. Vadim Tarasov is the director of the Institute for Translational Medicine and Biotechnology. He said the first group of volunteers is discharging on July 15th. The second group on July 20th.
The trial starting on the 18th of June, the first group had 18 volunteers and the second one had 23. The dose is given in both liquid and powder form. In order to save them from any other infection, they are kept in isolation.
Phase I was successful for the Russia COVID 19 vaccine. Phase II trials starting on July 13th, once it clears Phase II safely without any side effects it will move towards the Phase III human trials. (There’s no information on when Phase III trials will begin.)
As for its safety concern, Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University told the Russian media agency, “The safety of the vaccine is with surety. It corresponds to the safety of those vaccines that are currently on the market, the further vaccine development plan is already being taken by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production.”
Once all phases of the coronavirus vaccine human trial are successful, then only it will be commercially available for the use of the public. Also, if it clears all the stages, then Russia will become the first to develop the coronavirus vaccine.
Till then you will have to stay safe. Many pharma companies have developed medicine to help patients recover. Around 135 potential vaccines are at a preclinical stage. 23 vaccines are in the human trial phase of which 15 candidates are at Phase I trial.
For more updates on coronavirus cases and vaccines, Visit HealthClubFinder.